Stockreport

Puma Biotech cleared to trial Takeda-partnered breast cancer therapy in U.S. [Seeking Alpha]

Puma Biotechnology Inc  (PBYI) 
Last puma biotechnology inc earnings: 2/20 04:07 pm Check Earnings Report
US:NYSE Investor Relations: pumabiotechnology.com/ir.html
PDF alisertib, in-licensed from Takeda ( NYSE: TAK ), in patients with breast cancer. The study named ALISCA-Breast1 is designed to evaluate alisertib in combination with [Read more]